MyndTec Announces the North American Launch of Its Innovative Foot Drop FES Device MyndStep(TM)
MyndTec Announces the North American Launch of Its Innovative Foot Drop FES Device MyndStep(TM)
MyndStep™ is designed to improve mobility by providing functional electrical stimulation (FES) treatment to patients suffering from foot drop.
MyndStep™旨在通過為足下垂患者提供功能性電刺激(FES)治療來改善活動能力。
Mississauga, Ontario--(Newsfile Corp. - November 2, 2022) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging leader in neurological rehabilitation, is pleased to announce the launch of its newest product, MyndStepTM, to its functional electrical stimulation (FES) portfolio.
安大略省密西索加-(Newsfile Corp.-2022年11月2日)-MyndTec Inc.(CSE：MYTC)(“聯合科技公司“或”公司)，神經康復領域的新興領先者，很高興地宣佈推出其最新產品MyndStepTM，到其功能電刺激(FES)產品組合。
The launch of MyndStepTM will focus on leveraging MyndTec's expert capabilities in FES to pursue opportunities in the Medical Device and Foot Drop markets in both the United States and Canada.
MyndStep的推出TMMyndTec將專注於利用MyndTec在FES領域的專業能力，在美國和加拿大的醫療器械和足部下垂市場尋找機會。
"The addition of our newest FES lower body product MyndStep, reinforces our commitment to providing clinics, rehabilitation centers and physicians with innovative products focused on improving patient care and quality of life. We look forward to introducing this new product to our existing and new customers, and more importantly, introducing patients to an innovative technology which will help them regain function and mobility and Restore Independence, One Step At A Time," said Craig Leon, CEO of MyndTec Inc.
我們最新的FES下體產品MyndStep的加入，加強了我們為診所、康復中心和醫生提供專注於改善患者護理和生活質量的創新產品的承諾。我們期待着將這一新產品介紹給我們的現有和新客户，更重要的是，向患者介紹一種創新技術，幫助他們恢復功能和行動能力，並恢復獨立，一步一個腳印MyndTec Inc.首席執行官克雷格·利昂説。
MyndStep is intended to provide ankle dorsiflexion in individuals who have a dropped foot as a consequence of an upper motor neuron injury. An accelerometer and inclinometer is used to signal stimulation of the common peroneal nerve to facilitate motor output - ankle dorsiflexion - which clears the foot and toes of the ground's surface.
MyndStep旨在為因上運動神經元損傷而導致腳下垂的個人提供腳踝背屈。加速計和傾斜計被用來發出刺激腓總神經的信號，以促進運動輸出-腳踝背屈-這清除了腳部和腳趾的地面。
MyndStep Advantage and Convenience
MyndStep的優勢和便利性
Now available across the United States and Canada.
Easy Electrode Placement: convenient electrodes with magnetic snap connection, are placed on the peroneal nerve and tibialis anterior nerve.
Wearable Design: the device is small and light, with a rechargeable battery and can be worn in a cuff just below the knee.
Mobile Phone & Tablet Friendly: the MyndStepTM device is connected to a user app, available for download on iOS and Android, and is Bluetooth enabled.
App Functionality: the mobile app allows users to control the device more intuitively, and conveniently and provides real time treatment progress for users.
Electric Stimulation Intensity: is easily adjustable to suit any users preferred setting.
Built-in Smart Sensors: device has built-in sensors that can detect valid gait events and provide precise stimulation, producing a more normalized walking pattern. Users can monitor their improvement in walking pattern, distance and speed using their mobile device.
Suitable for home and outdoor use.
現在在美國和加拿大都可以買到。
輕鬆放置電極：在腓神經和脛前神經上放置帶有磁性卡扣連接的方便電極。
可穿戴設計：這款設備又小又輕，配有充電電池，可以戴在膝蓋以下的袖口裏。
手機和平板電腦友好The MyndStep：The MyndStepTM設備已連接到用户應用程序，可在上下載IOS和Android，並且是藍牙已啟用。
應用程序功能：該手機應用程序使用户可以更直觀、更方便地控制設備，併為用户提供實時的治療進度。
電刺激強度：可輕鬆調整，以適應任何用户偏好的設置。
內置智能傳感器：該設備具有內置傳感器，可以檢測有效的步態事件並提供精確的刺激，產生更歸一化的行走模式。用户可以使用他們的移動設備監控他們在行走模式、距離和速度方面的改善。
適用於居家和户外使用。
Treatment Modes:
治療模式：
Training Mode: to exercise the muscle and improve dorsiflexion.
Walking Mode: to help patients walk faster, more naturally and safely.
訓練方式：鍛鍊肌肉，提高背屈能力。
步行模式：幫助患者更快、更自然、更安全地行走。
To learn more about MyndStepTM, click the link or copy and paste the link into your browser:
要了解更多關於混合步驟TM, 單擊鏈接或複製鏈接並將其粘貼到瀏覽器中：
Foot Drop Facts:
腳下垂的事實：
North America is expected to hold a major market share in the global foot drop treatment market due to the high prevalence of stroke and an increasing number of product approvals. Foot drop can arise due to a stroke. According to the Centre for Disease Control and Prevention, around 795,000 people experience stroke every year in the United States(1). The Foot Drop Market compound annual growth rate forecast is expected to be 9.5% with North America representing one of the largest markets(1). More than 70% of hemiplegic patients who can regain walking ability, although they do not achieve good gait, can take advantage of a treatment such as MyndStep, designed to help patients to recover their gait and correct their Foot Drop ailment.
由於中風的高患病率和越來越多的產品批准，預計北美將在全球足部下垂治療市場佔據主要市場份額。中風會導致足部下垂。根據疾病控制和預防中心的數據，美國每年約有795,000人中風(1)。預計腳步下降市場的複合年增長率為9.5%，北美是最大的市場之一(1)。超過70%的偏癱患者可以恢復行走能力，儘管他們沒有達到良好的步態，但可以利用MyndStep等治療方法，旨在幫助患者恢復步態並糾正腳下垂疾病。
Sources:
(1) Mordor Intelligence: Foot Drop Treatment Market, Growth, Trends, Covid-19 Impact and Forecasts (2022-2027)
(2)
資料來源：
(1) 魔都智能：足下垂治療市場、增長、趨勢、新冠肺炎影響和預測(2022-2027)
(2)
About MyndTec
關於MyndTec
MyndTec is a Canadian medical technology company dedicated to the development and commercialization of innovative products that improve function, maximize independence and enhance the quality of life for individuals who have suffered injury to the central nervous system as a result of stroke, spinal cord injury and certain traumatic brain injuries. The Company develops non-invasive neurological and nervous system electrical stimulation therapeutics for the treatment of neurological diseases and injury specifically targeted to markets with large, growing and global patient populations.
MyndTec是一家加拿大醫療技術公司，致力於創新產品的開發和商業化，這些產品可以改善功能，最大限度地提高獨立性，並提高因中風、脊髓損傷和某些創傷性腦損傷而遭受中樞神經系統損傷的個人的生活質量。該公司開發非侵入性神經和神經系統電刺激療法，用於治療神經系統疾病和損傷，專門針對擁有大量、不斷增長的全球患者羣體的市場。
The Company's flagship product MyndMove™ is a non-invasive functional electrical stimulation-based intervention. MyndMove™ uses neuroplasticity mechanisms to stimulate development of new neural efferent and afferent pathways allowing patients to re-establish voluntary movement and improve independence in their activities of daily living. The MyndMove™ system offers trained therapists the ability to assist individuals affected with paralysis to improve voluntary control of their limbs. The MyndMove™ therapy system offers a broad spectrum of sophisticated functional electrical stimulation software protocols which therapists customize to patient needs to enable meaningful controlled movements via proprietary stimulation technology.
該公司的旗艦產品MyndMove™是一種基於電刺激的非侵入性功能性幹預產品。MyndMove™使用神經可塑性機制來刺激新的神經傳出和傳入路徑的發展，使患者能夠重新建立自願運動，並提高他們日常生活活動的獨立性。MyndMove™系統為訓練有素的治療師提供了幫助癱瘓患者改善對其肢體的自願控制的能力。MyndMove™治療系統提供了一系列複雜的功能性電刺激軟件協議，治療師根據患者的需要進行定製，通過專有的刺激技術實現有意義的可控運動。
For more information visit
有關更多信息，請訪問
Contact Information
聯繫信息
Craig Leon
MyndTec Inc. | Chief Executive Officer
investor.relations@myndtec.com
Tel: (416) 569-0430
克雷格·利昂
MyndTec Inc.|首席執行官
郵箱：investor.relationship@myndtec.com
電話：(416)569-0430
Bill Mitoulas
Venture North Capital Inc. | Principal
billm@venturenorthcapital.com
Tel: (416) 479-9547
比爾·米圖拉斯
Venture North Capital Inc.|負責人
郵箱：billm@venturenorecapal.com
電話：(416)479-9547
Cautionary Note Regarding Forward-Looking Statements
有關前瞻性陳述的注意事項
This news release contains forward-looking statements that constitute "forward-looking information" within the meaning of applicable Canadian securities laws (collectively, "forward-looking statements"). All statements in this news release that are not historical facts are forward-looking statements, including, but not limited to, all statements regarding: events, performance or results of operations that the Company believes, expects or anticipates will or may occur in the future; the duration of the Consulting Agreement, the services provided under the Consulting Agreement; and the consideration paid pursuant to the Consulting Agreement. Forward-looking statements are typically, but not always, identified by words such as: "believes", "expects", "aim", "anticipates", "intends", "estimates", "plans", "may", "should", "could", "continue", "would", "will", "potential", "scheduled", "goal", "target", or variations of such words and phrases and similar expressions, which, by their nature, refer to future events or results that may, could, would, might or will occur or be taken or achieved.
本新聞稿包含前瞻性陳述，構成適用加拿大證券法的“前瞻性信息”(統稱為“前瞻性陳述“)。本新聞稿中所有非歷史事實的陳述均為前瞻性陳述，包括但不限於以下所有陳述：公司相信、預期或預期未來將或可能發生的事件、業績或經營結果；諮詢協議的期限；根據諮詢協議提供的服務；以及根據諮詢協議支付的對價。前瞻性陳述通常但並非總是由下列詞語來標識：“相信”、“預期”、“目標”、“預期”、“打算”、“估計”、“計劃”、“可能”、“應該”、“可能”、“繼續”、“將”、“將”、“可能”、“預定”、“目標”、“目標”或此類詞語和短語的變體以及類似的表述，這些詞語和短語的本質是指可能、可能、將、可能或將會發生、被採取或實現。
Forward-looking statements are necessarily based on a number of estimates and assumptions that include, but are not limited to: expected future development; general economic conditions; the ability of the Company to execute on its business objectives; and other estimates and assumptions described in the Company's Listing Statement dated February 18, 2022 (the "Listing Statement"), a copy of which is available under the Company's profile on SEDAR at . Forward-looking statements are inherently subject to a number of significant risks and uncertainties that could cause the actual results or events to differ materially from those described in the forward-looking statements. Important risks and uncertainties that could cause actual results or events to differ materially from expectations include, but are not limited to: the Company's ability to continue as a going concern, the Company's research, development and commercialization of its products could be stopped or delayed if any third party fails to provide sufficient quantities of products or components, or fails to do so at acceptable quality levels or prices, or fails to maintain or achieve satisfactory regulatory compliance; the Company expects to incur significant ongoing costs and obligations relating to its investment in infrastructure, growth, research and development, regulatory compliance and operations; and other risks and uncertainties described in the Listing Statement. The Company has attempted to identify important factors that could cause actual results, performance or achievements to vary from those expectations expressed or implied by the forward-looking statements, however, there may be other factors that cause results, performance or achievements not to be as expected and that could cause actual results, performance or achievements to differ materially from current expectations. These forward-looking statements are only current as of the date of this news release. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties and the Company provides no assurance that they will prove to be correct. Readers should not place undue reliance on such forward-looking statements. The Company does not undertake any obligation to update forward-looking statements contained herein, other than as required by applicable law. All forward-looking statements are qualified in their entirety by this cautionary statement.
前瞻性陳述必須基於若干估計和假設，這些估計和假設包括但不限於：預期的未來發展；總體經濟狀況；公司執行其業務目標的能力；以及公司於2022年2月18日的上市聲明(“上市聲明”)中描述的其他估計和假設。上市聲明“)，其副本可在SEDAR上的公司簡介下查閲，網址為：。前瞻性陳述固有地受到許多重大風險和不確定因素的影響，這些風險和不確定因素可能導致實際結果或事件與前瞻性陳述中所描述的大不相同。可能導致實際結果或事件與預期大不相同的重要風險和不確定因素包括但不限於：如果任何第三方未能提供足夠數量的產品或部件，或未能以可接受的質量水平或價格這樣做，或未能維持或實現令人滿意的監管合規，公司作為持續經營企業繼續經營的能力，公司的產品研究、開發和商業化可能會停止或推遲；公司預計將產生與其基礎設施投資、增長、研發、監管合規和運營相關的重大持續成本和義務；以及上市聲明中描述的其他風險和不確定性。公司試圖確定可能導致實際結果、業績或成就與前瞻性陳述明示或暗示的預期不同的重要因素，然而，可能存在其他因素導致結果、業績或成就與預期不符，可能導致實際結果、業績或成就與當前預期大不相同。這些前瞻性陳述僅是截至本新聞稿發佈之日的最新情況。儘管本公司認為該等前瞻性陳述所反映的預期是合理的, 此類陳述涉及風險和不確定因素，公司不能保證這些陳述將被證明是正確的。讀者不應過分依賴這種前瞻性陳述。除適用法律要求外，公司不承擔更新本文中包含的前瞻性陳述的任何義務。所有前瞻性陳述均受本警告性聲明的限制。
The CSE has in no way passed upon the merits of the business of the Company and has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.
CSE絕不傳遞本公司業務的優點，既不批准或不批准本新聞稿的內容，也不對本新聞稿的充分性或準確性承擔任何責任。
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.
不得分發給美國新聞通訊社或在美國境內傳播。
To view the source version of this press release, please visit
要查看本新聞稿的源版本，請訪問
譯文內容由第三人軟體翻譯。